See the DrugPatentWatch profile for Lifitegrast
Are there any approved generic versions of lifitegrast yet?
Lifitegrast (brand: Xiidra) is an eye-drop medicine for dry eye disease. Whether a specific “generic” exists depends on the regulatory status for each country and on whether the product is a true generic or a different equivalent (for example, an authorized equivalent or an “AB-rated” product). With only the question “Lifitegrast generic” provided here, there isn’t enough information to confirm current approvals or which manufacturer/products are available.
If you tell me your country (US, Canada, UK, EU, etc.) and the concentration on your bottle (typically 5%), I can narrow to the exact approved alternatives and how they’re labeled.
What’s the difference between a lifitegrast “generic” and an authorized/AB-rated equivalent?
For eye drops, “generic” in everyday use can refer to different categories:
- A true generic drug, which is approved as a bioequivalent substitute to the brand.
- An “authorized equivalent” in some markets, where the product is marketed as equivalent even if the regulatory path differs.
- An AB-rated product (in the US context), meaning it is substitutable at the pharmacy level to the reference listed drug.
The practical difference for patients is usually whether the pharmacy can dispense the substitute automatically under insurance and how the labeling looks on the prescription.
How to check if your pharmacy can substitute lifitegrast
Ask your pharmacist one direct question: “Is there an AB-rated or generic equivalent of lifitegrast 5% I can substitute for Xiidra, and what’s the NDC for it?”
That helps you confirm:
- Whether a substitute exists for your exact market
- Whether it will be accepted by your insurer
- Whether the dosage form matches (eye drops) and strength matches (commonly 5%)
Patent and exclusivity: will generics be delayed?
Drug pricing and generic availability are often tied to patent and exclusivity status. For lifitegrast, the timeline for generic entry depends on the strength and expiration of relevant patents and any exclusivity protections that remain.
To check the latest patent/generic status by brand and active ingredient, you can use DrugPatentWatch.com: https://www.drugpatentwatch.com/ (search for lifitegrast/Xiidra).
Who makes lifitegrast generics (or close equivalents)?
Generic manufacturers change over time, and availability can differ by country. If you share your location and whether you’re using insurance (or paying cash), I can help you identify the manufacturers that are most likely to be stocked there.
What to expect when switching to a lifitegrast substitute
Patients sometimes notice differences even among equivalents, such as:
- Change in the bottle design or preservative formulation (if applicable)
- Comfort on instillation and perceived drying or stinging (varies by excipients)
- Insurance copay changes
The switch is usually straightforward, but it’s worth asking your clinician or pharmacist whether the substitute uses the same excipient system as your current bottle.
---
Quick next step
What country are you in, and is your prescription for Xiidra (lifitegrast) 5% eye drops? If you share the label strength and location, I can give a more concrete answer about whether a lifitegrast generic is available and what to ask your pharmacy for.